ONE AMGEN CENTER DRIVE, THOUSAND OAKS, CA
REPORTS SECOND QUARTER 2025 FINANCIAL RESULTS
Shareholder votes
REPORTS FIRST QUARTER 2025 FINANCIAL RESULTS
Annual Report to Security Holders
REPORTS FOURTH QUARTER AND FULL YEAR 2024 FINANCIAL RESULTS
Earnings Release
REPORTS SECOND QUARTER 2024 FINANCIAL RESULTS
Material disclosure
Q2
Q1
FY 2023
Q3
Registration Statement for Securities to be Offered to Employees
Prospectus Filed Pursuant to Rule 424(b)(2)
Prospectus filed pursuant to Rule 424(b)(3)
S-3ASR
Additional Proxy Materials
Additional Proxy Soliciting Materials
Definitive Proxy Statement
Statement of Changes in Beneficial Ownership
Notice of Proposed Sale of Securities
Annual Report of Employee Stock Purchase
Submission Upload
Correspondence
Free Writing Prospectus